Ghaggar River water not fit for drinking, bathing, ministry informs MP Kumari Selja in Lok Sabha
In his reply on August 8, Prataprao Jadhav, Minister of State in the Ministry of Health and Family Welfare, stated that the Ghaggar River is monitored at 18 locations in Punjab and nine locations in Haryana by the state or central pollution control board. 'CPCB has informed that the analysis of water quality monitoring results of river Ghaggar in the state of Punjab and Haryana for the year 2023 reveals that River Ghaggar is found non-complying w.r.t. notified Primary Water Quality Criteria for Outdoor Bathing at all the monitored locations in the state of Punjab and Haryana for the year 2023. The Haryana State Pollution Control Board has found the water of Ghaggar River not fit for drinking,' Jadhav stated.
On the steps taken by the governments in this regard, the minister stated, 'Under the centrally sponsored scheme of National River Conservation Plan, sewage treatment capacity of 15 million litres per day (MLD) was created in different towns in Punjab for conservation of Ghaggar River.'
'Punjab Pollution Control Board has informed that to treat wastewater from the towns in the catchment of river Ghaggar, 28 STPs of total capacity 291.7 MLD have been installed. Haryana State Pollution Control Board has informed that sewage treatment capacity of 588 MLD has been created in river catchment in the State under the Ghaggar Action Plan,' he added.
Quoting a 2024 Indian Council of Medical Research (ICMR) study, the minister's reply stated that the people dwelling near river drains were highly prone to cancer and 'hazard quotients were observed above the threshold limit that poses high non-carcinogenic risks'. He added that the results of the study had revealed that lead, iron, and aluminium exceeded the permissible limit of the CPCB.
Giving details about the number of cancer cases, the minister stated figures from 2019 to 2023. 'As per the Indian Council of Medical Research's National Cancer Registry Programme (ICMR-NCRP), the estimated number of incidences of cancer cases in Haryana during the last five years (2019-2023) is 1,468 in 2019, 1,536 in 2020, 1,580 in 2021, 1,630 in 2022, and 1,678 in 2023,' Jadhav stated.
Saying that cancer care facilities are available at government medical colleges in Hisar, Karnal, Nuh, Sonipat and Rohtak districts, the minister stated that further comprehensive cancer care services are provided at the National Cancer Institute in Bhadsa district.
'Under the strengthening of Tertiary Cancer Care Centres facilities, Atal Cancer Care Centre (ACCC) has been established at Sub Divisional Civil Hospital (SDCH), Ambala Cantonment. It is equipped with latest equipment for cancer treatment, and comprehensive cancer care services are provided to needy patients not only from Haryana but also neighbouring states,' Jadhav stated.
He further said that the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD) is being implemented in all 22 districts of Haryana. 'Under NP-NCD, 22 district NCD clinics, 157 community health centre NCD clinics, and 5 District Cancer Care Centres are functional at Panchkula, Ambala, Faridabad, Kurukshetra and Yamunanagar. Further, 5 Day Care Cancer Centres have been approved for the State of Haryana,' he added.
Jadhav further said that cancer treatment is either free or subsidised in government institutions, adding that financial assistance is also provided to poor patients under the health minister's Cancer Patient Fund component of the umbrella scheme of the Rashtriya Arogya Nidhi.
'Pradhan Mantri Jan Arogya Yojana (PMJAY) aims at providing health insurance cover of Rs. 5 lakhs per family per year for secondary and tertiary care hospitalization. Since the inception of the scheme, treatment for cancer diseases is included in the benefit packages. All modes of treatment for cancer (Medical Oncology, Surgical Oncology and Radiation Oncology) are covered under the scheme,' the minister added.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
5 hours ago
- Mint
Baby food: Regulator plans to cut sugar levels further in bid to curb obesity, diabetes rates in India
New Delhi: Babies aren't going to like this even one bit, but India's top food safety regulator is looking to tighten limits on the sugar content in their food. The Food Safety and Standards Authority of India (FSSAI) is considering new rules to reduce the amount of sugar added to foods for toddlers and babies aged 6 to 24 months. The move, which could affect popular products such as infant cereals and milk formulae, is part of an effort to fight the country's rising rates of obesity and diabetes. Currently, these products contain sugar within legally permitted limits, but the food regulator says it's time for even more drastic steps. As per the National Family Health Survey-5 (2019-21), the percentage of children under 5 years who are overweight (weight-for-height) increased to 3.4 percent from 2.1 percent in NFHS-4 (2015-16). The survey showed 24% of women and 23% of men are overweight or obese. The proposal would build on current norms that ban added sugar in food for the youngest babies – from birth to 6 months. If approved, the new rules would mark a significant step toward ensuring healthier food options for the country's youngest children. 'The matter of reducing sugar in baby food for those 6 to 24 months of age was discussed at a meeting last week with experts from FSSAI, the health ministry and the Indian Council of Medical Research. Even ICMR-National Institute of Nutrition dietary guidelines do not recommend sugar for children up to 2 years. The matter has been kept for wider consideration and will be taken up in the next meeting," an official familiar with the matter said. The baby food market in India, valued at $1.16 billion in 2024, is projected to grow to $1.98 billion by 2030, according to MarkNtel Advisors, driven by growing urbanization, more working mothers and increased parental awareness of nutrition. Push for healthier habits FSSAI's 2020 regulations for infant nutrition mandate that lactose and glucose polymers as the primary carbohydrates in baby food. Sucrose and fructose are strongly discouraged and cannot exceed 20% of the total carbohydrates, a rule aimed at limiting added sugars. The regulator's initiative to reduce sugar in baby food is part of a larger public health campaign. A recent study in The Lancet projected that India could have the world's second-highest obesity burden by 2035, with 449 million overweight and obese people. The FSSAI also considered a report from a Swiss non-profit that found added sugar in a popular baby product, highlighting the need for stricter regulations. 'The regulator is taking its role seriously by examining the ingredients in baby foods and pushing for even better standards. A decision on the new rules is expected soon," said a second person aware of the matter. The FSSAI regularly tests and samples infant food products. During an enforcement drive in 2024, it found that five of 99 samples tested were deemed unsafe. Doctors weigh in Medical experts support the proposal. Dr. Nishant Wadhwa, a senior pediatrician at Sir Ganga Ram Hospital in New Delhi, explained that babies and toddlers are not equipped to handle large amounts of sugar. 'The body is not naturally inclined or trained to handle sugar surge even for adults," he said. 'When babies consume too much sugar, their bodies can't process it and the excess is stored as fat. This can lead to serious health issues such as early-onset fatty liver disease." Dr. Wadhwa emphasized that babies don't need any extra sugar. "The sugar which the baby is actually taking in mother's milk is lactose," he explained, adding that added sugars like sucrose and fructose should be totally avoidable. He advised parents to provide home-cooked food rather than packaged cereal-based pre-mixed products. Industry and expert support The International Pediatric Association (IPA) viewed the FSSAI's initiative as a positive step. Dr. Naveen Thacker, the IPA's executive director, said, 'It is a welcome move by FSSAI to reduce the sugar limit in food for babies aged 6 to 24 months." He encouraged breastfeeding for babies and toddlers up to two years old and stressed that the IPA does not promote formula milk or packaged cereal-based food or pre-mixes unless absolutely necessary. ICMR experts emphasized that reducing sugar in baby food is crucial as babies and toddlers don't need sugar. 'The focus is on limiting extra sweetness, not natural sugars like lactose. A taste for sugar is learned early in life. If children get used to very sweet foods, they are more likely to crave sugar as they get older, which can lead to health problems. The ICMR's dietary guidelines recommend that children under 2 don't need any added sugar at all. These guidelines also recommend that adults limit sugar intake to no more than 25 grams per day, or about 5% of a 2,000-calorie diet," said an ICMR scientist. Last year, reports claimed Nestle's products in South Asia (including India), Africa and Latin America contained significantly higher sugar levels than those in Europe. "We adhere to all existing regulations, ensuring that none of our infant formula and milk products for infants and young children contain added refined sugar. We reduced added sugar in Cerelac by up to 30% in the last five years and recently introduced a new Cerelac range with 'no refined sugar' option," a Nestle India spokesperson said. Queries by the union health ministry spokesperson, FSSAI and popular baby food brands like Slurrp Farm, Amul on and Abbott remained unanswered till press time.
Time of India
14 hours ago
- Time of India
Lab-grown rabies antibodies show promise as safe alternative
MUMBAI: India's public hospitals and dispensaries may soon have a safer, more affordable option for preventing rabies after a suspected rabid dog bite: one already in use in private clinics since 2017 and by BMC since 2019. Tired of too many ads? go ad free now A post-marketing clinical trial involving more than 4,000 participants, conducted and funded by a pharmaceutical company and recently published in The Lancet, could now pave the way for its large-scale public use. For decades, the life-saving protocol has been the same across public or private health set ups: wash the wound, inject a dose of rabies immunoglobulin if the bite is severe, and follow with multiple doses of anti-rabies vaccine. The possible shift lies in the kind of immunoglobulin used. The relatively new lab-made candidate could replace the animal and human derived versions in use since the 1970s. An immunoglobulin is a concentrated solution of antibodies, injected directly into and around the bite, that offers immediate but short-term protection against the virus, effectively buying time until the vaccine takes full effect. The earliest ones in use were derived either from rabies-vaccinated horses (Equine Rabies Immunoglobulin - ERIG) or human donated plasma (Human Rabies Immunoglobulin - HRIG). In 2016, (SII) received permission to make immunoglobulin which has monoclonal (lab-made,RmAb) antibodies. "Most private facilities at least in Mumbai have phased out the use of the horse-derived one. While it has been proven safe at large, there are risks associated; it can cause mild allergic reactions or in rare cases a serious adverse event," said Dr Trupti Gilada, city-based infectious disease specialist. The private facilities have moved on to either the human derived or lab-made ones. "Both, human derived one and the lab-made one have high efficacy. Tired of too many ads? go ad free now The former has risk of infection transmission, though rare. The ones made in labs are safer and more easily available due to ease of largescale production," said Dr Mandar Kubal, another infectious disease specialist. A survey by ICMR published in July on the availability of anti-rabies vaccine and rabies immunoglobulin in health facilities found that, of the 534 facilities surveyed across 15 states and 60 districts -- 467 in the public sector -- 78% still used horse derived immunoglobulin. But even that was out of stock for most apart from a small 20.3% of those surveyed. While BMC uses the lab-made alternative, it is no stranger to shortages; at the moment it is short of rabies vaccine shots. A doctor from one of the four BMC-run medical college hospitals, said, "Mumbai has a heavy burden of dog bite cases and early on BMC decided to move on from animal derived ones due to risks associated. We either use generic human derived immunoglobulin or largely lab-made alternatives." But this lab-made alternative is still to make its way into National Guidelines for Rabies Prophylaxis. The ICMR survey states, "RmAb presents as a promising alternative to both HRIG and ERIG. Compared to ERIG, RmAb offers the potential scope for large-scale production with standardised quality, elimination of animal use in the manufacturing, & reduced risk of adverse events. "It is cheaper compared to HRIG. Studies have shown that RmAbs are safe for human use, but... [there is] a need for larger clinical trials and post-marketing surveillance to assess the safety and efficacy of RmAbs in the Indian setting." The Serum Institute-funded post marketing trial of its lab-made product compared with horse-derived immunoglobulin found to be equally effective in preventing rabies, with slightly higher average antibody levels on day 14.
The Hindu
a day ago
- The Hindu
Six deliveries per thousand are stillbirths in India, highest rate in northern states: study
Over six in every one thousand deliveries in India in 2020 could have been a stillbirth, with higher rates among urban mothers compared to rural, according to an analysis of data from national surveys and the civil registration system. Researchers, including those from the All India Institute of Medical Sciences, Gorakhpur, and the Indian Council of Medical Research, New Delhi, also identified that stillbirth hotspots are located primarily in northern and central India. Chandigarh, Jammu and Kashmir, and Rajasthan in north India recorded the highest rates of stillbirth, the findings published inThe Lancet Regional Health Southeast Asia journal show. The team analysed data gathered from the fifth round of the National Family Health Survey (NFHS) and the 2020 report of the civil registration system, which is managed by the Ministry of Home Affairs and records vital events, including births, deaths and stillbirths across India. "The nationwide stillbirth rate (SBR) in 2020 was 6.548 per 1,000 total births (female: 6.54; male: 6.63). Stillbirth rates were higher among urban mothers compared to rural mothers," the authors wrote. A higher rate of stillbirth was also found in districts where pregnant women were anaemic (deficient in iron) and underweight -- factors known to increase risk of adverse birth outcomes, including stillbirth. Hygienic menstrual practices and caesarean (C-section) deliveries -- in which a baby is delivered through a surgical procedure -- were associated with a lower rate of stillbirth, especially in Telangana, Karnataka, and Tamil Nadu. The results were in line with data from NFHS-5, according to which the prevalence of C-section deliveries was about 45 per cent in south India in 2019-2020, the authors said. Evidence from states including Assam, Meghalaya, Maharashtra, Uttar Pradesh, Himachal Pradesh and Chhattisgarh showed that receiving at least four pre-delivery check-ups and adhering to iron and folic acid supplementation during pregnancy can significantly reduce the risk of stillbirth, the team said. Overall, higher rates of stillbirths were found in regions where pregnant women were anaemic, more deliveries were occurring in public health facilities and a larger fraction of women were having a lower wealth status, they said. However, there were no disparities in sex-specific rates of stillbirth across the country's districts, even though a higher rate of stillbirths seen among male foetuses may point to a higher biological vulnerability, the researchers said.
